Trials / Completed
CompletedNCT07169721
CIRCAdian Rhythm of the IMMune Age IndeX (IMMAX)
CIRCAdian Rhythm of the IMMune Age IndeX (CIRCA-IMMAX) - Influence of Circadian Rhythm on the Determination of an Immune Age Metric
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Leibniz Research Centre for Working Environment and Human Factors · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to evaluate the influence of circadian rhythms on the determination of an individual's immune age. The biomarker IMMAX was calculated for 50 participants aged 20-69 at 8 a.m., 1 p.m. and 6 p.m. on the same day.
Conditions
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2024-03-28
- Completion
- 2024-04-22
- First posted
- 2025-09-12
- Last updated
- 2025-09-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT07169721. Inclusion in this directory is not an endorsement.